Mecamylamine adverse reactions: Difference between revisions
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
'''Cardiovascular:''' Orthostatic [[dizziness ]]and [[syncope]], [[postural hypotension]]. | '''Cardiovascular:''' Orthostatic [[dizziness ]]and [[syncope]], [[postural hypotension]]. | ||
'''Nervous System/Psychiatric:''' [[Convulsions]], choreiform movements, mental aberrations, [[tremor]], and [[paresthesias ]](see WARNINGS). | '''Nervous System/Psychiatric:''' [[Convulsions]], choreiform movements, mental aberrations, [[tremor]], and [[paresthesias ]](see [[Mecamylamine warnings|WARNINGS]]). | ||
'''Respiratory:''' Interstitial [[pulmonary edema ]]and [[fibrosis]]. | '''Respiratory:''' Interstitial [[pulmonary edema ]]and [[fibrosis]]. |
Revision as of 14:50, 10 March 2014
Mecamylamine |
---|
Mecamylamine tablet®, Vecamyl® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Contraindications |
Warnings |
Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
How Supplied/Storage and Handling |
Patient Counseling Information |
Labels and Packages |
Clinical Trials on Mecamylamine |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
ADVERSE REACTIONS
The following adverse reactions have been reported and within each category are listed in order of decreasing severity.
Gastrointestinal: Ileus, constipation (sometimes preceded by small, frequent liquid stools), vomiting, nausea, anorexia, glossitis and dryness of mouth.
Cardiovascular: Orthostatic dizziness and syncope, postural hypotension.
Nervous System/Psychiatric: Convulsions, choreiform movements, mental aberrations, tremor, and paresthesias (see WARNINGS).
Respiratory: Interstitial pulmonary edema and fibrosis.
Urogenital: Urinary retention, impotence, decreased libido.
Special Senses: Blurred vision, dilated pupils.
Miscellaneous: Weakness, fatigue, sedation.[1]
References
- ↑ "VECAMYL (MECAMYLAMINE HYDROCHLORIDE) TABLET [MANCHESTER PHARMACEUTICALS]". Retrieved 10 March 2014.